Abstract Library

The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.

1

Are All Routine Spondyloarthritis Outpatient Visits Considered Useful by Rheumatologists? An Exploratory Clinical Practice Study

J Rheumatol. 2022 Nov;49(11):1214-1220. doi: 10.3899/jrheum.220037. Epub 2022 Jun 1.

 

Kasper Hermans 1Annelies Boonen 2Astrid van Tubergen 2

2

The association between ankylosing spondylitis and psychiatric disorders: Insights from a population based cross-sectional database

J Affect Disord. 2023 Feb 15;323:788-792. doi: 10.1016/j.jad.2022.12.024. Epub 2022 Dec 12.

 

Mahmud Omar 1Niv Ben-Shabat 2Avishai M Tsur 3Arnon D Cohen 4Abdulla Watad 5Howard Amital 2Kassem Sharif 6

3

Disease activity indexes might not capture the same disease aspects in males and females with ankylosing spondylitis: A real-world nationwide analysis

Front Med (Lausanne). 2022 Dec 21;9:1078325. doi: 10.3389/fmed.2022.1078325.eCollection 2022.

Cristina Fernández-Carballido 1Vega Jovaní 2Emma Beltrán Catalán 3Manuel José Moreno-Ramos 4Jesús Sanz Sanz 5Adela Gallego 6M Luz García Vivar 7José Manuel Rodríguez-Heredia 8Cristina Sanabra 9Carlos Sastré 9

4

Infliximab biosimilar-to-biosimilar switching in patients with inflammatory rheumatic disease: clinical outcomes in real-world patients from the DANBIO registry

RMD Open. 2022 Nov;8(2):e002560.doi: 10.1136/rmdopen-2022-002560.

 

Hafsah Nabi 1 2Oliver Hendricks 3 4Dorte Vendelbo Jensen 5 6Anne Gitte Loft 7 8Jens Kristian Pedersen 9 10Søren Andreas Just 11Kamilla Danebod 12Heidi Lausten Munk 13Salome Kristensen 14Natalia Manilo 15Ada Colic 16Asta Linauskas 17 18Pia Høger Thygesen 19Louise Brot Christensen 5Maren Høgberget Kalisz 5Niels Lomborg 20Stavros Chrysidis 21Johnny Lillelund Raun 22Marlene Andersen 23Frank Mehnert 24Niels Steen Krogh 25Merete Lund Hetland # 26 2Bente Glintborg # 26 2

5

Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis

Rheumatol Int. 2022 Nov 28. doi: 10.1007/s00296-022-05248-4. Online ahead of print.

 

Stefan Kleinert 1 2Florian Schuch 3Praxedis Rapp 3Monika Ronneberger 3Joerg Wendler 3Patrizia Sternad 4Florian Popp 4Peter Bartz-Bazzanella 5Cay von der Decken 6Kirsten Karberg 7Georg Gauler 8Patrick Wurth 8Susanna Späthling-Mestekemper 9Christoph Kuhn 10Matthias Englbrecht 11Wolfgang Vorbrüggen 12Georg Adler 13Martin Welcker 4

6

Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study

Arthritis Rheumatol. 2022 Dec;74(12):1943-1958.doi: 10.1002/art.42282. Epub 2022 Nov 7.

 

Xenofon Baraliakos 1Atul Deodhar 2Maxime Dougados 3Lianne S Gensler 4Anna Molto 3Sofia Ramiro 5Alan J Kivitz 6Denis Poddubnyy 7Marga Oortgiesen 8Thomas Vaux 9Carmen Fleurinck 10Julie Shepherd-Smith 9Christine de la Loge 10Natasha de Peyrecave 10Désirée van der Heijde 11

7

The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondyloarthritis

Rheumatology (Oxford). 2022 Nov 28;61(12):4741-4751. doi: 10.1093/rheumatology/keac174.

 

Michael Nissen 1Bénédicte Delcoigne 2Daniela Di Giuseppe 2Lennart Jacobsson 3Merete Lund Hetland 4 5Adrian Ciurea 6Lucie Nekvindova 7 8Florenzo Iannone 9Nurullah Akkoc 10Tuulikki Sokka-Isler 11Karen Minde Fagerli 12Maria Jose Santos 13 14Catalin Codreanu 15Manuel Pombo-Suarez 16Ziga Rotar 17 18Bjorn Gudbjornsson 19 20Irene van der Horst-Bruinsma 21Anne Gitte Loft 22 23Burkhard Möller 24Herman Mann 25Fabrizio Conti 26Gozde Yildirim Cetin 27Heikki Relas 28Brigitte Michelsen 29 30Pedro Avila Ribeiro 31Ruxandra Ionescu 32Carlos Sanchez-Piedra 33Matija Tomsic 17 18Árni Jón Geirsson 34Johan Askling 35 36Bente Glintborg 37 38Ulf Lindström 39

8

Impairment in cognitive function in patients with axial spondyloarthritis and psoriatic arthritis

Rheumatol Int. 2022 Nov 28. doi: 10.1007/s00296-022-05248-4. Online ahead of print.

 

Stefan Kleinert 1 2Florian Schuch 3Praxedis Rapp 3Monika Ronneberger 3Joerg Wendler 3Patrizia Sternad 4Florian Popp 4Peter Bartz-Bazzanella 5Cay von der Decken 6Kirsten Karberg 7Georg Gauler 8Patrick Wurth 8Susanna Späthling-Mestekemper 9Christoph Kuhn 10Matthias Englbrecht 11Wolfgang Vorbrüggen 12Georg Adler 13Martin Welcker 4

9

Safety and Efficacy of Bimekizumab in Patients With Active Ankylosing Spondylitis: Three-Year Results From a Phase IIb Randomized Controlled Trial and Its Open-Label Extension Study

Arthritis Rheumatol. 2022 Dec;74(12):1943-1958.doi: 10.1002/art.42282. Epub 2022 Nov 7.

 

Xenofon Baraliakos 1Atul Deodhar 2Maxime Dougados 3Lianne S Gensler 4Anna Molto 3Sofia Ramiro 5Alan J Kivitz 6Denis Poddubnyy 7Marga Oortgiesen 8Thomas Vaux 9Carmen Fleurinck 10Julie Shepherd-Smith 9Christine de la Loge 10Natasha de Peyrecave 10Désirée van der Heijde 11

10

Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial

Ann Rheum Dis. 2022 Nov;81(11):1515-1523. doi: 10.1136/ard-2022-222608.Epub 2022 Jul 4.

 

Désirée van der Heijde 1Xenofon Baraliakos 2Joachim Sieper 3Atul Deodhar 4Robert D Inman 5Hideto Kameda 6Xiaofeng Zeng 7Yunxia Sui 8Xianwei Bu 8Aileen L Pangan 8Peter Wung 8In-Ho Song 8

11

Disease activity in women with ankylosing spondylitis remains higher under Tumour Necrosis Factor inhibitor treatment than in men: a five-year observational study

Scand J Rheumatol. 2022 Nov;51(6):506-512.doi: 10.1080/03009742.2021.1967046. Epub 2021 Nov 2.

 

T Rusman 1M T Nurmohamed 1 2S Hoekstra 1C J van Denderen 2R F van Vollenhoven 1M Boers 1 3M M Ter Wee 1 3I E van der Horst-Bruinsma 1

12

Prevalence and Radiographic Progression of Hip Involvement in Patients With Ankylosing Spondylitis Treated With Tumor Necrosis Factor Inhibitors

J Rheumatol. 2022 Nov 1;jrheum.220061. doi: 10.3899/jrheum.220061. Online ahead of print.

 

Maria Konsta 1Michael T Nurmohamed 1Alexios Iliopoulos 1Petros P Sfikakis 1J Christiaan van Denderen 1Ingrid Visman 1Grigorios T Sakelariou 1Irene E van der Horst-Bruinsma 1

13

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

Rheumatol Ther. 2022 Nov 4. doi: 10.1007/s40744-022-00504-2. Online ahead of print.

 

Martin J Bergman 1Patrick Zueger 2Jayeshkumar Patel 2Christopher D Saffore 3Ia Topuria 4Cristi Cavanaugh 4Siran Fang 2Jerry Clewell 2Alexis Ogdie 5

14

Management of Axial Spondyloarthritis - Insights into Upadacitinib

Drug Des Devel Ther. 2022 Oct 19;16:3609-3620. doi: 10.2147/DDDT.S330413.eCollection 2022.

 

Jürgen Braun 1Uta Kiltz 1Xenofon Baraliakos 1

15

Systematic Literature Review of the Use of Productivity Losses/Gains in Cost-Effectiveness Analyses of Immune-Mediated Disorders

Adv Ther. 2022 Dec;39(12):5327-5350. doi: 10.1007/s12325-022-02321-z.Epub 2022 Oct 7.

 

Akira Yuasa 1Naohiro Yonemoto 1Kazumasa Kamei 1Toshiaki Murofushi 2Michael LoPresti 2Ankush Taneja 3Jake Horgan 4Shunya Ikeda 5

16

Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms

Curr Rheumatol Rep. 2022 Oct;24(10):310-320. doi: 10.1007/s11926-022-01084-4.Epub 2022 Jul 21.

 

Hoi Ki Joshua Tam 1Philip C Robinson 2 3Peter Nash 4

17

Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis

Ann Rheum Dis. 2022 Oct 21;ard-2022-223298. doi: 10.1136/ard-2022-223298.Online ahead of print.

 

Casper Webers 1 2Augusta Ortolan 3 4Alexandre Sepriano 4 5Louise Falzon 6Xenofon Baraliakos 7Robert B M Landewé 8 9Sofia Ramiro 4 9Désirée van der Heijde 4Elena Nikiphorou 4 10 11

18

Surgery for degenerative cervical myelopathy in patients with rheumatoid arthritis and ankylosing spondylitis: a nationwide registry-based study with patient-reported outcomes

Acta Neurochir (Wien). 2022 Oct 15. doi: 10.1007/s00701-022-05382-9. Online ahead of print.

 

Siril T Holmberg 1 2Agnete M Gulati 3Tonje Okkenhaug Johansen 4 5Øyvind O Salvesen 6Vetle Vangen Lønne 4 5Tore K Solberg 7 8Erling A Tronvik 5 9Øystein P Nygaard 4 5 10Sasha Gulati 4 5 10

19

Further Simplified Clinimetry Using a Multidimensional Health Assessment Questionnaire

J Rheumatol. 2022 Oct 1;jrheum.220769. doi: 10.3899/jrheum.220769. Online ahead of print.

 

Juan Schmukler 1Theodore Pincus 1

20

Pneumococcal vaccination among adult risk patient with axial spondyloarthritis in Switzerland: Data from the survey of the ankylosing spondylitis association of Switzerland (SVMB)

Vaccine. 2022 Oct 12;40(43):6206-6210. doi: 10.1016/j.vaccine.2022.09.056. Epub 2022 Sep 26.

 

Sandro T Stoffel 1Angelo Colaninno 2René Bräm 2Matthias Schwenkglenks 3

21

ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

Ann Rheum Dis. 2022 Oct 21;ard-2022-223296. doi: 10.1136/ard-2022-223296.Online ahead of print.

 

Sofia Ramiro 1 2Elena Nikiphorou 3 4Alexandre Sepriano 3 5Augusta Ortolan 6Casper Webers 7Xenofon Baraliakos 8Robert B M Landewé 9 10Filip E Van den Bosch 11 12Boryana Boteva 13Ann Bremander 14 15Philippe Carron 11 12Adrian Ciurea 16Floris A van Gaalen 3Pál Géher 17Lianne Gensler 18Josef Hermann 19Manouk de Hooge 11Marketa Husakova 20Uta Kiltz 8Clementina López-Medina 21 22Pedro M Machado 23 24 25Helena Marzo-Ortega 26Anna Molto 27Victoria Navarro-Compán 28Michael J Nissen 29Fernando M Pimentel-Santos 5Denis Poddubnyy 30Fabian Proft 30Martin Rudwaleit 31Mark Telkman 32Sizheng Steven Zhao 33Nelly Ziade 34 35Désirée van der Heijde 3

22

Why do some patients have severe sacroiliac disease but no syndesmophytes in Ankylosing Spondylitis? Data from a Nested Case-Control Study

J Rheumatol. 2022 Oct 1;jrheum.211230. doi: 10.3899/jrheum.211230. Online ahead of print.

 

Lauren K Ridley 1Mark C Hwang 1John D Reveille 1Lianne S Gensler 1Mariko L Ishimori 1Matthew A Brown 1Mohammad H Rahbar 1Amirali Tahanan 1Michael M Ward 1Michael H Weisman 1Thomas J Learch 1

23

Mortality in Ankylosing Spondylitis According to Treatment: A Nationwide Retrospective Cohort Study of 5,900 Patients From Israel

Arthritis Care Res (Hoboken). 2022 Oct;74(10):1614-1622. doi: 10.1002/acr.24616.Epub 2022 Jun 28.

 

Niv Ben-Shabat # 1Aviv Shabat # 2Abdulla Watad 3Khalaf Kridin 4Nicola Luigi Bragazzi 5Dennis McGonagle 6Doron Comaneshter 7Arnon D Cohen 8Howard Amital 9

24

Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis

J Manag Care Spec Pharm. 2022 Sep;28(9):1008-1020. doi: 10.18553/jmcp.2022.28.9.1008.

 

Alexis Ogdie 1Mark Hwang 2Phani Veeranki 3 4Alexandria Portelli 3Steven Sison 3Jason Shafrin 3 5Sofia Pedro 6Nina Kim 7Esther Yi 8Kaleb Michaud 6 9

25

Driving Difficulties in Patients With Axial Spondyloarthritis: Results From the Scotland Registry for Ankylosing Spondylitis

Arthritis Care Res (Hoboken). 2022 Sep;74(9):1541-1549. doi: 10.1002/acr.24595.Epub 2022 Jun 29.

 

LaKrista Morton 1Gary J Macfarlane 1Gareth Jones 1Karen Walker-Bone 2Rosemary Hollick 1

26

Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort

Rheumatology (Oxford). 2022 Aug 11;keac432. doi: 10.1093/rheumatology/keac432.Online ahead of print.

 

Mikhail Protopopov 1Fabian Proft 1Stephanie Wichuk 2Pedro M Machado 3Robert G Lambert 4Ulrich Weber 5Susanne Juhl Pedersen 6 7Mikkel Østergaard 6 7Joachim Sieper 1Martin Rudwaleit 8Xenofon Baraliakos 9Walter P Maksymowych 2Denis Poddubnyy 1 10

27

Effects of patient and disease characteristics on global functioning in patients with axial spondyloarthritis in routine care

Semin Arthritis Rheum. 2022 Aug;55:152006. doi: 10.1016/j.semarthrit.2022.152006.Epub 2022 Apr 15.

 

Uta Kiltz 1Thomas Wiatr 2Imke Redeker 2Xenofon Baraliakos 2Kirill Fedorov 2J Braun 2

28

The genetic backbone of ankylosing spondylitis: how knowledge of genetic susceptibility informs our understanding and management of disease

Rheumatol Int. 2022 Aug 8. doi: 10.1007/s00296-022-05174-5.Online ahead of print.

 

Marcus Kenyon 1Sinead Maguire 2Anna Rueda Pujol 3Finbar O'Shea 2Ross McManus 3

29

Upadacitinib for the treatment of active non-radiographic axial spondyloarthritis (SELECT-AXIS 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Lancet. 2022 Jul 30;400(10349):369-379.doi: 10.1016/S0140-6736(22)01212-0.

 

Atul Deodhar 1Filip Van den Bosch 2Denis Poddubnyy 3Walter P Maksymowych 4Désirée van der Heijde 5Tae-Hwan Kim 6Mitsumasa Kishimoto 7Ricardo Blanco 8Yuanyuan Duan 9Yihan Li 9Aileen L Pangan 9Peter Wung 9In-Ho Song 9

30

Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-a Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease

J Pers Med. 2022 Jul 19;12(7):1174. doi: 10.3390/jpm12071174.

 

Maurizio Benucci 1Arianna Damiani 1Edda Russo 2Francesca Li Gobbi 1Valentina Grossi 3Amedeo Amedei 2Maria Infantino 3Mariangela Manfredi 3

31

Sleep and spa therapies: What is the role of balneotherapy associated with exercise? A systematic review

Front Physiol. 2022 Aug 10;13:964232. doi: 10.3389/fphys.2022.964232. eCollection 2022.

 

Lucia Castelli 1Letizia Galasso 1Antonino Mulè 1Andrea Ciorciari 1Francesca Fornasini 2Angela Montaruli 1 3Eliana Roveda 1 3Fabio Esposito 1 3

32

Pregnancy and neonatal outcomes in women with axial spondyloarthritis: pooled data analysis from the European Network of Pregnancy Registries in Rheumatology (EuNeP)

Ann Rheum Dis. 2022 Aug 12;annrheumdis-2022-222641. doi: 10.1136/ard-2022-222641.Online ahead of print.

 

Yvette Meissner 1Anja Strangfeld 2 3Anna Molto 4 5Frauke Forger 6Marianne Wallenius 7 8Nathalie Costedoat-Chalumeau 9 10Hilde Bjørngaard 8Marion Couderc 11 12René-Marc Flipo 13Gaëlle Guettrot-Imbert 9Isabell Haase 14Bente Jakobsen 8Hege Suorza Svean Koksvik 8Christophe Richez 15 16Jérémie Sellam 17 18Anja Weiß 2Astrid Zbinden 6Rebecca Fischer-Betz 19

33

Certolizumab Pegol Efficacy in Patients With Non-Radiographic Axial Spondyloarthritis Stratified by Baseline MRI and C-Reactive Protein Status: An Analysis From the C-axSpAnd Study

ACR Open Rheumatol. 2022 Sep;4(9):794-801. doi: 10.1002/acr2.11469. Epub 2022 Jun 22.

 

Philip C Robinson 1Walter P Maksymowych 2Lianne S Gensler 3Stephen Hall 4Martin Rudwaleit 5Bengt Hoepken 6Lars Bauer 6Thomas Kumke 6Mindy Kim 7Natasha de Peyrecave 8Atul Deodhar 9

34

Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies

Semin Arthritis Rheum. 2022 Jul 21;56:152074.doi: 10.1016/j.semarthrit.2022.152074. Online ahead of print.

 

Christian Lynæs 1Maria Lynæs 2Lee S Simon 3Peter Tugwell 4Maria-Antonietta D'Agostino 5Vibeke Strand 6Carsten B Juhl 7Sabrina M Nielsen 8Maarten De Witt 9Dorcas Beaton 10Lara J Maxwell 11Alexa S Meara 12Robin Christensen 13on-behalf-of-the-OMERACT-Technical-Advisory-Group-(TAG)

35

Survey of current practices in the management of anti-TNF failure in juvenile spondyloarthritis

Clin Exp Rheumatol. 2022 Jul;40(7):1442-1446. doi: 10.55563/clinexprheumatol/gyrtjo.Epub 2022 Apr 20.

 

Hemalatha Srinivasalu 1Melissa Oliver 2Matthew L Stoll 3Pamela F Weiss 4Robert A Colbert 5CARRA Juvenile Spondyloarthritis Workgroup

36

Efficacy and safety of ixekizumab treatment in patients with axial spondyloarthritis: 2-year results from COAST

RMD Open. 2022 Jul;8(2):e002165. doi: 10.1136/rmdopen-2021-002165.

 

Jürgen Braun 1Uta Kiltz 2Atul Deodhar 3Tetsuya Tomita 4Maxime Dougados 5Rebecca Bolce 6David Sandoval 6Chen-Yen Lin 6Jessica Walsh 7

37

Minimal Impact of the COVID-19 Pandemic on Disease Activity and Health-Related Quality of Life in Patients With Ankylosing Spondylitis Receiving Bimekizumab: Exploratory Analyses From a Phase 2b Open-Label Extension Study

ACR Open Rheumatol. 2022 Jul 14;10.1002/acr2.11486. doi: 10.1002/acr2.11486.Online ahead of print.

 

Philip C Robinson 1Pedro M Machado 2Nigil Haroon 3Lianne S Gensler 4John D Reveille 5Vanessa Taieb 6Thomas Vaux 7Carmen Fleurinck 8Marga Oortgiesen 9Natasha de Peyrecave 8Atul Deodhar 10

38

Upadacitinib in active ankylosing spondylitis: results of the 2-year, double-blind, placebo-controlled SELECT-AXIS 1 study and open-label extension

RMD Open. 2022 Jul;8(2):e002280.doi: 10.1136/rmdopen-2022-002280.

 

Désirée van der Heijde 1Atul Deodhar 2Walter P Maksymowych 3Joachim Sieper 4Filip Van den Bosch 5Tae-Hwan Kim 6Mitsumasa Kishimoto 7Andrew J Östör 8Bernard Combe 9Yunxia Sui 10Yuanyuan Duan 10Peter K Wung 10In-Ho Song 10

39

Simplified Ankylosing Spondylitis Disease Activity Score (SASDAS) Versus ASDAS: A Post Hoc Analysis of a Randomized Controlled Trial

J Rheumatol. 2022 Jul 15;jrheum.211075. doi: 10.3899/jrheum.211075. Online ahead of print.

 

Emilce E Schneeberger 1Gustavo Citera 1Dario Ponce de Leon 1Annette E Szumski 1Kenneth Kwok 1Mariel Cutri 1Maxime Dougados 1

40

The risk of inflammatory bowel disease in patients with axial spondyloarthritis treated with biologic agents: BSRBR-AS and meta-analysis

J Rheumatol. 2022 Jul 1;jrheum.211034. doi: 10.3899/jrheum.211034. Online ahead of print.

 

Gary J Macfarlane 1Renke Biallas 1Linda E Dean 1Gareth T Jones 1Nicola J Goodson 1Ovidiu Rotariu 1

41

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity

Arthritis Res Ther. 2022 Jul 7;24(1):163. doi: 10.1186/s13075-022-02853-3.

 

P R Sternes 1L Brett 2J Phipps 3F Ciccia 4T Kenna 5 6E de Guzman 5 3K Zimmermann 6M Morrison 7G Holtmann 8E Klingberg 9D Mauro 4C McIvor 2H Forsblad-d'Elia 9M A Brown 10 11

42

A brief human history of ankylosing spondylitis: A scoping review of pathogenesis, diagnosis, and treatment

Surg Neurol Int. 2022 Jul 15;13:297. doi: 10.25259/SNI_294_2022. eCollection 2022.

 

Sierra N Murphy 1Brandon A Nguyen 1Rohin Singh 1Nolan J Brown 2Shane Shahrestani 3Matthew T Neal 3Naresh P Patel 3Maziyar A Kalani 3

43

Effect of tofacitinib on pain, fatigue, health-related quality of life and work productivity in patients with active ankylosing spondylitis: results from a phase III, randomised, double-blind, placebo-controlled trial

RMD Open. 2022 Jun;8(2):e002253. doi: 10.1136/rmdopen-2022-002253.

 

Victoria Navarro-Compán 1James Cheng-Chung Wei 2 3Filip Van den Bosch 4 5Marina Magrey 6Lisy Wang 7Dona Fleishaker 7Joseph C Cappelleri 7Cunshan Wang 7Joseph Wu 7Oluwaseyi Dina 8Lara Fallon 9Vibeke Strand 10

44

Interim 2-Year Analysis from SERENA: A Real-World Study in Patients with Psoriatic Arthritis or Ankylosing Spondylitis Treated with Secukinumab

Rheumatol Ther. 2022 Jun 8;1-14. doi: 10.1007/s40744-022-00460-x. Online ahead of print.

 

Uta Kiltz 1 2Petros P Sfikakis 3Karl Gaffney 4Andreas Bounas 5Nicola Gullick 6 7Eric Lespessailles 8Jan Brandt-Juergens 9Rasho Rashkov 10Barbara Schulz 11Effie Pournara 11Piotr Jagiello 11

45

Perioperative risk stratification of spine trauma patients with ankylosing spinal disorders: a comparison of 3 quantitative indices

J Neurosurg Spine. 2022 May 27;1-7. doi: 10.3171/2022.4.SPINE211449. Online ahead of print.

 

Nikita Lakomkin 1Anthony L Mikula 1Zachariah W Pinter 1Elizabeth Wellings 1Mohammed Ali Alvi 1Kristen M Scheitler 1Zach Pennington 1Nathan J Lee 2Brett A Freedman 1Arjun S Sebastian 1Jeremy L Fogelson 1Mohamad Bydon 1Michelle J Clarke 1Benjamin D Elder 1

46

Defining and managing flares in axial spondyloarthritis

Curr Opin Rheumatol. 2022 Jul 1;34(4):195-202.doi: 10.1097/BOR.0000000000000883. Epub 2022 Jun 9.

 

Krystel Aouad 1 2Laure Gossec 1 3

47

Cardiovascular Morbidity in Ankylosing Spondylitis: A Focus on Inflammatory Cardiac Disease

Cureus. 2022 Jun 3;14(6):e25633. doi: 10.7759/cureus.25633.eCollection 2022 Jun.

 

Pradnya Brijmohan Bhattad 1Mugdha Kulkarni 2Parasbhai D Patel 3Mazen Roumia 1

48

Children With Enthesitis-Related Arthritis and Possible Benefits From Treatments for Adults With Spondyloarthritis

Arthritis Care Res (Hoboken). 2022 Jul;74(7):1058-1064. doi: 10.1002/acr.24529.Epub 2022 Apr 15.

 

Pamela F Weiss 1Robert C Fuhlbrigge 2Emily von Scheven 3Daniel J Lovell 4Robert A Colbert 5Hermine I Brunner 4PRCSG Advisory Council and the CARRA Executive Committee

49

Identifying inadequate response among patients with ankylosing spondylitis and psoriatic arthritis prescribed advanced therapy in a real-world, commercially insured adult population in the USA

Clin Rheumatol. 2022 Jun 7. doi: 10.1007/s10067-022-06230-y. Online ahead of print.

 

Theresa Hunter 1Michael Grabner 2Julie Birt 3Keith Isenberg 4Mingyang Shan 3Chia-Chen Teng 2Jianmin Wu 3Kirstin Griffing 3Jeffrey Lisse 3Jeffrey R Curtis 5

50

Concurrence of Rheumatoid Arthritis and Ankylosing Spondylitis: Analysis of Seven Cases and Literature Review

Case Rep Rheumatol. 2022 May 28;2022:8500567.doi: 10.1155/2022/8500567. eCollection 2022.

 

Bryan-Josué Flores-Robles 1Eztizen Labrador-Sánchez 1Estíbaliz Andrés-Trasahedo 1Valvanera Pinillos-Aransay 1María-Yasmina Joven-Zapata 2Laura Torrecilla Lerena 2Osman-Alberto Salazar-Asencio 3Juan-Antonio López-Martín 1

51

Mortality Rates in Patients With Ankylosing Spondylitis With and Without Extraarticular Manifestations and Comorbidities: A Retrospective Cohort Study

J Rheumatol. 2022 Jul;49(7):688-693. doi: 10.3899/jrheum.210909. Epub 2022 Apr 15.

 

Erin Kelty 1Milica Ognjenovic 2Warren D Raymond 2Charles A Inderjeeth 3Helen I Keen 4David B Preen 5Johannes C Nossent 3

52

Malignancy in ankylosing spondylitis: a cross-sectional analysis of a large population database

BMC Rheumatol. 2022 Jun 30;6(1):44. doi: 10.1186/s41927-022-00275-x.

 

Mohamad Bittar 1Sali Merjanah 2 3Reem Alkilany 3Marina Magrey 4

53

Does Gender Impact a Diagnosis of Ankylosing Spondylitis?

ACR Open Rheumatol. 2022 Jun;4(6):540-546. doi: 10.1002/acr2.11428. Epub 2022 Mar 29.

 

Mark C Hwang 1Martin Rozycki 2David Kauffman 3Theresa Arndt 2Esther Yi 4Michael H Weisman 5

54

Secukinumab for the treatment of psoriasis, psoriatic arthritis, and axial spondyloarthritis: Physical and pharmacological properties underlie the observed clinical efficacy and safety

Pharmacol Ther. 2022 Jan;229:107925. doi: 10.1016/j.pharmthera.2021.107925.Epub 2021 Jun 23.

 

Frank Kolbinger 1Franco Di Padova 2Atul Deodhar 3Jason E Hawkes 4Christine Huppertz 2Torsten Kuiper 2Iain B McInnes 5Christopher T Ritchlin 6David Rosmarin 7Georg Schett 8José M Carballido 2Peter Häusermann 9Claudio Calonder 2Beate Vogel 2Jean-Michel Rondeau 2Gerard Bruin 2

55

Fertility and pregnancy outcomes in women with spondyloarthritis: a systematic review and meta-analysis

Rheumatology (Oxford). 2022 Apr 11;61(4):1314-1327.doi: 10.1093/rheumatology/keab589.

 

Sabrina Hamroun 1Aghilès Hamroun 2Jean-Joël Bigna 3Edem Allado 4Frauke Förger 5Anna Molto 6

56

Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review

BMC Musculoskelet Disord. 2022 Mar 12;23(1):240.doi: 10.1186/s12891-022-05073-7.

 

Philip Mease 1Atul Deodhar 2

57

Improvement of Functioning and Health With Ixekizumab in the Treatment of Active Nonradiographic Axial Spondyloarthritis in a 52-Week, Randomized, Controlled Trial

Arthritis Care Res (Hoboken). 2022 Mar;74(3):451-460. doi: 10.1002/acr.24482.Epub 2022 Jan 26.

 

Jessica A Walsh 1Marina N Magrey 2Xenofon Baraliakos 3Kentaro Inui 4Meng-Yu Weng 5Ennio Lubrano 6Désirée van der Heijde 7Annelies Boonen 8Lianne S Gensler 9Vibeke Strand 10Jürgen Braun 3Theresa Hunter 11Xiaoqi Li 11Baojin Zhu 11Luis León 11David Marcelino Sandoval Calderon 11Uta Kiltz 3

58

Secukinumab and Sustained Reduction in Fatigue in Patients With Ankylosing Spondylitis: Long-Term Results of Two Phase III Randomized Controlled Trials

Arthritis Care Res (Hoboken). 2022 May;74(5):759-767. doi: 10.1002/acr.24517.Epub 2022 Mar 10.

 

Tore K Kvien 1Philip G Conaghan 2Laure Gossec 3Vibeke Strand 4Mikkel Østergaard 5Denis Poddubnyy 6Nicole Williams 7Brian Porter 8Abhijit Shete 9Isabelle Gilloteau 9Atul Deodhar 10

59

Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials

Adv Ther. 2022 Jun;39(6):2806-2819.doi: 10.1007/s12325-022-02132-2. Epub 2022 Apr 16.

 

Irene E van der Horst-Bruinsma 1Kurt de Vlam 2Jessica A Walsh 3Rebecca Bolce 4Theresa Hunter 4David Sandoval 4Danting Zhu 4Vladimir Geneus 4Enrique R Soriano 5Marina Magrey 6

60

The effect of exercise training programs with aerobic components on C-reactive protein, erythrocyte sedimentation rate and self-assessed disease activity in people with ankylosing spondylitis: A systematic review and meta-analysis

Int J Rheum Dis. 2022 Mar 10. doi: 10.1111/1756-185X.14315. Online ahead of print.

 

Conrad Harpham 1Quillon K Harpham 2Alan R Barker 1

61

Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials

Semin Arthritis Rheum. 2022 Jun;54:151996.doi: 10.1016/j.semarthrit.2022.151996. Epub 2022 Mar 19.

 

Anh Ho 1Ibrahim Younis 1Quang A Le 2

62

Treatment of axial spondyloarthritis: an update

Nat Rev Rheumatol. 2022 Apr;18(4):205-216. doi: 10.1038/s41584-022-00761-z.Epub 2022 Mar 10.

 

Abhijeet Danve 1Atul Deodhar 2

63

Predicting Probability of Response to Tumor Necrosis Factor Inhibitors for Individual Patients With Ankylosing Spondylitis

JAMA Netw Open. 2022 Mar 1;5(3):e222312.doi: 10.1001/jamanetworkopen.2022.2312.

 

Runsheng Wang 1 2Abhijit Dasgupta 3 4Michael M Ward 3

64

Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1

BMC Musculoskelet Disord. 2021 Dec 13;22(1):1037.doi: 10.1186/s12891-021-04930-1.

Jürgen Braun 1Bjoern Buehring 2Xenofon Baraliakos 2Lianne S Gensler 3Brian Porter 4Erhard Quebe-Fehling 5Sibylle Haemmerle 5

65

The effectiveness of group and home-based exercise on psychological status in people with ankylosing spondylitis: A systematic review and meta-analysis

Musculoskeletal Care. 2022 Apr 18. doi: 10.1002/msc.1641. Online ahead of print.

 

Brian Lane 1Ruth McCullagh 1Jefferson R Cardoso 2Joseph G McVeigh 1

66

Waiting for JAK inhibitor safety data

RMD Open. 2022 Feb;8(1):e002236.doi: 10.1136/rmdopen-2022-002236.

 

Tue Wenzel Kragstrup 1 2Bente Glintborg 3 4Annemarie L Svensson 5Christopher McMaster 6 7 8Philip C Robinson 9 10Bent Deleuran 11 12David Fl Liew 13 7 14

67

Impact of filgotinib on sacroiliac joint magnetic resonance imaging structural lesions at 12 weeks in patients with active ankylosing spondylitis (TORTUGA trial)

Rheumatology (Oxford). 2022 May 5;61(5):2063-2071.doi: 10.1093/rheumatology/keab543.

 

Walter P Maksymowych 1Mikkel Østergaard 2 3Robert Landewé 4William Barchuk 5Ke Liu 5Chantal Tasset 6Leen Gilles 7Thijs Hendrikx 8Robin Besuyen 9Xenofon Baraliakos 10

68

Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension

Arthritis Rheumatol. 2022 Jan;74(1):70-80.doi: 10.1002/art.41911. Epub 2021 Nov 12.

 

Atul Deodhar 1Désirée van der Heijde 2Joachim Sieper 3Filip Van den Bosch 4Walter P Maksymowych 5Tae-Hwan Kim 6Mitsumasa Kishimoto 7Andrew Ostor 8Bernard Combe 9Yunxia Sui 10Alvina D Chu 10In-Ho Song 10

69

The Interplay Between COVID-19 and Spondyloarthritis or Its Treatment

J Rheumatol. 2022 Feb;49(2):225-229. doi: 10.3899/jrheum.210742. Epub 2021 Oct 1.

 

James T Rosenbaum 1Michael H Weisman 2Hedley Hamilton 3Cassie Shafer 4Elin Aslanyan 4Richard A Howard 4Kimberly Ogle 5John D Reveille 6Kevin L Winthrop 7Dongseok Choi 7

70

Long-term safety and clinical outcomes of certolizumab pegol treatment in patients with active non-radiographic axial spondyloarthritis: 3-year results from the phase 3 C-axSpAnd study

RMD Open. 2022 Mar;8(1):e002138.doi: 10.1136/rmdopen-2021-002138.

 

Désirée van der Heijde 1Lianne S Gensler 2Walter P Maksymowych 3Robert Landewé 4 5Martin Rudwaleit 6Lars Bauer 7Thomas Kumke 7Mindy Kim 8Simone Emanuele Auteri 9Bengt Hoepken 7Atul Deodhar 10

71

Performance and Predictors of Minimal Disease Activity Response in Patients With Peripheral Spondyloarthritis Treated With Adalimumab

Arthritis Care Res (Hoboken). 2022 Feb;74(2):259-267. doi: 10.1002/acr.24442.Epub 2021 Dec 29.

Laura C Coates 1Sonya Abraham 2William Tillett 3Philip J Mease 4Sofia Ramiro 5Tianshuang Wu 6Xin Wang 6Aileen L Pangan 6In-Ho Song 6

72

All-Cause and Cause-Specific Mortality in Psoriatic Arthritis and Ankylosing Spondylitis: A Systematic Review and Meta-Analysis

Arthritis Care Res (Hoboken). 2021 Nov 17. doi: 10.1002/acr.24820. Online ahead of print.

Haseeb Chaudhary 1, Nidrit Bohra 1, Khezar Syed 1, Anthony Donato 1, M Hassan Murad 2, Paras Karmacharya 3 4

73

A Road Map of the Axial Spondyloarthritis Continuum

Mayo Clin Proc. 2022 Jan;97(1):134-145. doi: 10.1016/j.mayocp.2021.08.007.Epub 2021 Nov 18.

Sergio Schwartzman 1, Eric M Ruderman 2

74

IL-23 and axial disease: do they come together?

Rheumatology (Oxford). 2021 Oct 19;60(Suppl 4):iv28-iv33.doi: 10.1093/rheumatology/keab617.

Philip Mease 1 2, Filip van den Bosch 3

75

Subcutaneous Infliximab, CT-P13 SC: A Profile of Its Use in the EU

Clin Drug Investig. 2021 Dec;41(12):1099-1107. doi: 10.1007/s40261-021-01093-8.Epub 2021 Nov 2.

Matt Shirley 1

76

Comparison of Outcomes in Percutaneous Fixation of Traumatic Fractures between Ankylosing Spondylitis and Diffuse Idiopathic Skeletal Hyperostosis

Global Spine J. 2021 Oct 20;21925682211052003. doi: 10.1177/21925682211052003.Online ahead of print.

Scott McCarty 1, Jacob J Bruckner 2, Jael E Camacho 2, Julio J Jauregui 2, Alexandra E Thomson 2, Ivan Ye 2, Daniel L Cavanaugh 2, Eugene Y Koh 2, Steven C Ludwig 2, Daniel E Gelb 2

77

ACR Appropriateness Criteria® Inflammatory Back Pain: Known or Suspected Axial Spondyloarthritis: 2021 Update

J Am Coll Radiol. 2021 Nov;18(11S):S340-S360.doi: 10.1016/j.jacr.2021.08.003.

Expert Panel on Musculoskeletal Imaging; Gregory J Czuczman 1, Jacob C Mandell 2, Daniel E Wessell 3, Leon Lenchik 4, Shivani Ahlawat 5, Jonathan C Baker 6, R Carter Cassidy 7, Jennifer L Demertzis 8, Hillary W Garner 9, Alan Klitzke 10, Jennifer R Maynard 11, Jennifer L Pierce 12, Charles Reitman 13, Ralf Thiele 14, William J Yost 15, Francesca D Beaman 16

78

Geographic Variations in Diagnosis and Treatment of Ankylosing Spondylitis in the United States: A Real-World Study

Rheumatol Ther. 2021 Dec 19. doi: 10.1007/s40744-021-00406-9. Online ahead of print.

Atul Deodhar 1, Denise Kruzikas 2, Lili Zhou 2, Ana Biljan 2, Christopher D Saffore 2

79

Impact of age on mortality and complications in patients with Ankylosing Spondylitis spine fractures

J Clin Neurosci. 2022 Jan;95:188-197. doi: 10.1016/j.jocn.2021.11.035. Epub 2021 Dec 17.

Mayur Sharma 1, Nikhil Jain 1, Dengzhi Wang 1, Beatrice Ugiliweneza 2, Maxwell Boakye 3, Doniel Drazin 4

80

Treatment Responses in Patients With Psoriatic Arthritis Axial Disease According to Human Leukocyte Antigen-B27 Status: An Analysis From the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry

ACR Open Rheumatol. 2022 Feb 26.doi: 10.1002/acr2.11416. Online ahead of print.

Philip J Mease 1, Soumya D Chakravarty 2, Robert R McLean 3, Taylor Blachley 3, Toana Kawashima 3, Iris Lin 4, Arthur Kavanaugh 5, Alexis Ogdie 6

81

Mandatory nonmedical switching from originator to biosimilar infliximab in patients with inflammatory arthritis and psoriasis in British Columbia: a cohort study

CMAJ Open. 2022 Feb 15;10(1):E109-E118. doi: 10.9778/cmajo.20200319. Print Jan-Mar 2022.

Anat Fisher 1, Jason D Kim 2, Colin R Dormuth 2

82

Efficacy and Drug Survival after Switching from Etanercept to the Biosimilar SB4: A Real-Life Long-Term Study

J Clin Med. 2022 Jan 26;11(3):621. doi: 10.3390/jcm11030621.

Simone Parisi 1, Andrea Becciolini 2, Maria Chiara Ditto 1, Davide Rozza 3, Anna Zanetti 3, Angela Laganà 1, Clara Lisa Peroni 1, Chiara Centanaro Di Vittorio 1, Rosanna Degiovanni 1, Cristina Realmuto 1, Carlo Alberto Scirè 3, Marta Priora 4, Eleonora Di Donato 2, Daniele Santilli 2, Flavio Mozzani 2, Gianluca Lucchini 2, Alarico Ariani 2, Lucia Gardelli 5, Francesco Girelli 5, Eugenio Arrigoni 6, Ilaria Platè 6, Elena Bravi 6, Marino Paroli 7, Rosalba Caccavale 7, Carlo Salvarani 8, Gilda Sandri 8, Federica Lumetti 9, Alessandro Volpe 10, Antonio Marchetta 10, Enrico Fusaro 1

83

Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1)

Rheumatol Adv Pract. 2021 Dec 4;5(3):rkab098. doi: 10.1093/rap/rkab098. eCollection 2021.

Stephanie Rose Harrison 1 2, Marco Garrido-Cumbrera 3 4, Victoria Navarro-Compán 5, José Correa-Fernández 3, Dale Webb 6, Laura Christen 7, Helena Marzo-Ortega 1 2

84

Prevalence of Frailty in Ankylosing Spondylitis, Psoriatic Arthritis, and Rheumatoid Arthritis: Data from a National Claims Dataset

ACR Open Rheumatol. 2022 Jan 5. doi: 10.1002/acr2.11388. Online ahead of print.

Sarah B Lieber 1 2, Iris Navarro-Millán 1 2, Mangala Rajan 2, Jeffrey R Curtis 3, Sebastian E Sattui 4, Geyanne Lui 5, Sergio Schwartzman 1 2, Lisa A Mandl 1 2

85

Diagnostic delay in axial spondyloarthritis: a systematic review

Clin Rheumatol. 2022 Feb 19. doi: 10.1007/s10067-022-06100-7.Online ahead of print.

Charles A Hay 1, Jon Packham 1 2 3, Sarah Ryan 3 4, Christian D Mallen 1 3, Alexandros Chatzixenitidis 1, James A Prior 5 6

86

Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs

RMD Open. 2022 Jan;8(1):e001777. doi: 10.1136/rmdopen-2021-001777.

Monica Schwartzman 1, Joerg Ermann 2, Kristine A Kuhn 3, Sergio Schwartzman 4, Michael H Weisman 5

87

Patient Perspectives on Biologics for Axial Spondyloarthritis in a Cross-sectional Study in a Predominantly Female Population: Treatment Satisfaction, Wear-off Between Doses, and Use of Supplemental Medication

Rheumatol Ther. 2021 Dec 27. doi: 10.1007/s40744-021-00417-6. Online ahead of print.

W Benjamin Nowell 1, Kelly Gavigan 2, Theresa Hunter 3, Rebecca J Bolce 3, Jeffrey R Lisse 3, Carol Himelein 3, Suchita Dubey 3, Jeffrey R Curtis 4, Jessica A Walsh 5

88

Changes in ankylosing spondylitis incidence, prevalence and time to diagnosis over two decades

MD Open. 2021 Dec;7(3):e001888. doi: 10.1136/rmdopen-2021-001888.

Samantha S R Crossfield 1 2, Helena Marzo-Ortega 2 3, Sarah R Kingsbury 2 3, Mar Pujades-Rodriguez 4, Philip G Conaghan 2 3

89

Evaluation of Clinical Diagnosis of Axial Psoriatic Arthritis (PsA) or Elevated Patient-reported Spine Pain in CorEvitas' PsA/Spondyloarthritis Registry

J Rheumatol. 2021 Dec 1;jrheum.210662. doi: 10.3899/jrheum.210662. Online ahead of print.

Alexis Ogdie 1, Taylor Blachley 1, Paul R Lakin 1, Blessing Dube 1, Robert R McLean 1, Peter Hur 1, Philip J Mease 1

90

Determinants of the Physician Global Assessment of Disease Activity and Influence of Contextual Factors in Early Axial Spondyloarthritis

Arthritis Care Res (Hoboken). 2022 Feb;74(2):268-273. doi: 10.1002/acr.24465.Epub 2022 Jan 13.

Fumio Hirano 1Robert B M Landewé 2Floris A van Gaalen 1Désirée van der Heijde 1Cécile Gaujoux-Viala 3Sofia Ramiro 4

91

Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data

Eur J Health Econ. 2022 Feb 3. doi: 10.1007/s10198-022-01429-x. Online ahead of print

Aileen R Neilson 1Gareth T Jones 2Gary J Macfarlane 2Ejaz Mi Pathan 3Paul McNamee 4

92

Advances in treatment of axial spondyloarthritis are associated with improved patient outcomes: data from the Ankylosing Spondylitis Registry of Ireland (ASRI)

Rheumatol Int. 2022 Jan 28. doi: 10.1007/s00296-021-05067-z. Online ahead of print.

Sinead Maguire 1 2Gillian Fitzgerald 3 4Phil Gallagher 5Finbar O'Shea 6 7

93

Disruption of c-MYC Binding and Chromosomal Looping Involving Genetic Variants Associated With Ankylosing Spondylitis Upstream of the RUNX3Promoter

Front Genet. 2022 Jan 7;12:741867. doi: 10.3389/fgene.2021.741867. eCollection 2021.

Carla J Cohen 1 2Connor Davidson 1 2 3Carlo Selmi 4Paul Bowness 1 2Julian C Knight 3B Paul Wordsworth 1 2Matteo Vecellio 1 2 4

94

Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy

Scand J Rheumatol. 2022 Jan 20;1-8. doi: 10.1080/03009742.2021.2007609.Online ahead of print.

S Maguire 1 2F Wilson 3P Gallagher 4F D O'Shea 1 2

95

Chronic Pain and Assessment of Pain Sensitivity in Patients With Axial Spondyloarthritis: Results From the SPARTAKUS Cohort

J Rheumatol. 2021 Nov;48(11):1672-1679. doi: 10.3899/jrheum.200872. Epub 2020 Dec 15.

Elisabeth Mogard 1Tor Olofsson 2Stefan Bergman 3Ann Bremander 4Lars Erik Kristensen 5Jack Kvistgaard Olsen 6Johan K Wallman 2Elisabet Lindqvist 2

96

Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry

Rheumatology (Oxford). 2021 Dec 1;60(12):5795-5800.doi: 10.1093/rheumatology/keab070.

Xabier Michelena 1 2Sizheng Steven Zhao 3Sayam Dubash 1 2Linda E Dean 4Gareth T Jones 4Helena Marzo-Ortega 1 2

97

Concurrent chronic hyperplastic candidosis and oral lichenoid lesion as adverse events of secukinumab therapy

Aust Dent J. 2021 Sep;66(3):340-345. doi: 10.1111/adj.12833.Epub 2021 Mar 5.

C S Farah 1 2 3

98

Clinical Manifestations and Diagnosis of Axial Spondyloarthritis

J Clin Rheumatol. 2021 Dec 1;27(8):e547-e560.doi: 10.1097/RHU.0000000000001575.

Jessica A Walsh 1Marina Magrey 2

99

Understanding Fatigue-Related Disability in Rheumatoid Arthritis and Ankylosing Spondylitis: The Importance of Daily Correlates

Arthritis Care Res (Hoboken). 2021 Sep;73(9):1282-1289. doi: 10.1002/acr.24224.Epub 2021 Aug 6.

Roisin S M Hegarty 1Tamlin S Conner 1Simon Stebbings 2Benjamin D Fletcher 1Andrew Harrison 3Gareth J Treharne 1

100

What Have We Learned From Family-Based Studies About Spondyloarthritis?

Front Genet. 2021 Jun 3;12:671306. doi: 10.3389/fgene.2021.671306.eCollection 2021.

Félicie Costantino 1 2Hendrick Mambu Mambueni 1Roula Said-Nahal 1 2Henri-Jean Garchon 1 3Maxime Breban 1 2

101

Imaging in Axial Spondyloarthritis: What is Relevant for Diagnosis in Daily Practice?

Curr Rheumatol Rep. 2021 Jul 3;23(8):66. doi: 10.1007/s11926-021-01030-w.

Ulrich Weber 1Anne Grethe Jurik 2 3 4Robert G W Lambert 5 6Walter P Maksymowych 7

102

Effects of a 6-month exercise programme on disease activity, physical and functional parameters in patients with ankylosing spondylitis: Randomised controlled trial

S Afr J Physiother. 2021 Jun 29;77(1):1546. doi: 10.4102/sajp.v77i1.1546.eCollection 2021.

Kim Nolte 1Dina C Janse van Rensburg 2Lizelle Fletcher 3

103

Subjective loss of clinical response to TNFi in axSpA relates to recurrence of MRI bone marrow oedema particularly with long-acting agents

Rheumatology (Oxford). 2021 Jul 17;keab571. doi: 10.1093/rheumatology/keab571.Online ahead of print.

Stephanie R Harrison 1 2Rebecca Ansell 1 3Hannah R Mathieson 1 2 3Mira Merashli 4Noemi Busquets-Péez 5Dennis McGonagle 1 2Helena Marzo-Ortega 1 2

104

Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy

Med Clin North Am. 2021 Mar;105(2):325-339. doi: 10.1016/j.mcna.2020.10.001.Epub 2021 Jan 14.

Philip J Mease 1

105

A Phase III Randomized Study of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, for Active Ankylosing Spondylitis

Rheumatol. 2021 Feb 15;jrheum.201088. doi: 10.3899/jrheum.201088. Online ahead of print.

Peter C Taylor 1Désirée van der Heijde 1Robert Landewé 1Shannon McCue 1Sue Cheng 1Annelies Boonen 1

106

Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review

BioDrugs. 2021 Mar;35(2):175-186. doi: 10.1007/s40259-021-00467-w. Epub 2021 Feb 17.

Elisabetta Chessa 1Matteo Piga 2Alberto Floris 1Mattia Congia 1Ignazio Cangemi 1Alessandro Mathieu 1Alberto Cauli 1

107

Revision and 90-day mortality following hip arthroplasty in patients with inflammatory arthritis and ankylosing spondylitis enrolled in the National Joint Registry for England and Wales

Hip Int. 2021 Feb 18;1120700021990592. doi: 10.1177/1120700021990592. Online ahead of print.

Laura L Miller 1Daniel Prieto-Alhambra 2Lea Trela-Larsen 1J Mark Wilkinson 3Emma M Clark 1Ashley W Blom 1Alexander J MacGregor 4

108

Primary Total Hip Arthroplasty in Patients With Ankylosing Spondylitis

J Arthroplasty. 2021 Jul;36(7S):S282-S289. doi: 10.1016/j.arth.2021.01.054. Epub 2021 Jan 23.

Brandon R Bukowski 1Nicholas J Clark 1Michael J Taunton 1Brett A Freedman 1Daniel J Berry 1Matthew P Abdel 1

109

Axial spondyloarthritis: new advances in diagnosis and management

BMJ. 2021 Jan 4;372:m4447. doi: 10.1136/bmj.m4447.

Christopher Ritchlin 1Iannis E Adamopoulos 2

110

A retrospective review of the adverse effects of biological therapy and reasons for its discontinuation in a resource-limited setting

S Afr Med J. 2020 Nov 27;110(12):1231-1237. doi: 10.7196/SAMJ.2020.v110i12.14695.

J W Rood 1R Du Toit

111

Increased proportion of comorbidities but no deterioration of sexual QOL during a 5-year follow-up in patients with axSpA in the biologic treatment era

Rheumatology (Oxford). 2021 Jan 7;keaa887. doi: 10.1093/rheumatology/keaa887.Online ahead of print.

Kari Hansen Berg 1Gudrun Rohde 1 2Are Pripp 3Anne Prøven 4Esben Ester Pirelli Benestad 1Monika Østensen 2Glenn Haugeberg 2 5

112

Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study

Clin Exp Rheumatol. 2021 Jan 6. Online ahead of print.

Salvatore D'Angelo 1Nazzarena Malavolta 2Cinzia Scambi 3Carlo Salvarani 4Francesco Caso 5Enrico Tirri 6Roberta Ramonda 7Laura Quarta 8Gian Luca Erre 9Marta Riva 10Rosario Buono 11Federica Furini 12Rosa Daniela Grembiale 13Claudia Lomater 14Fabrizio Cantini 15Tiziana Maio 16Maria Sole Chimenti 17Rossana Scrivo 18Fausto Salaffi 19Roberto F Caporali 20Paola Volpe 21Giuliana Gualberti 22Francesca Marando 22Antonio Marchesoni 23

113

Treat-to-target in axial spondyloarthritis: an observational study in daily practice

Rheumatology (Oxford). 2021 Jun 27;keab516. doi: 10.1093/rheumatology/keab516.Online ahead of print.

Esther Beckers 1 2Annelies Boonen 1 2Casper Webers 1 2Peter Ten Klooster 3Harald Vonkeman 3 4Monique Efdé 5Astrid van Tubergen 1 2

114

Chronic back pain in first-degree relatives (FDRs) of patients with ankylosing spondylitis: predictive value of HLA-B27 and persistence of inflammatory back pain over time

RMD Open. 2020 Nov;6(3):e001418. doi: 10.1136/rmdopen-2020-001418.

Karim Doughem 1Michael H Weisman 2Michael M Ward 3Lianne S Gensler 4Mariko Ishimori 5Amirali Tahanan 6David C Kung 7Laura Diekman 8MinJae Lee 9Mohammad Hossein Rahbar 6John D Reveille 8

115

Identifying Patients With Axial Spondyloarthritis in Large Datasets: Expanding Possibilities for Observational Research

J Rheumatol. 2021 May;48(5):685-692. doi: 10.3899/jrheum.200570. Epub 2020 Sep 1.

Jessica A Walsh 1Shaobo Pei 2Gopi K Penmetsa 2Rebecca S Overbury 2Daniel O Clegg 2Brian C Sauer 2

116

Impact of Secukinumab on Patient-Reported Outcomes in the Treatment of Ankylosing Spondylitis: Current Perspectives

Open Access Rheumatol. 2020 Nov 26;12:277-292. doi: 10.2147/OARRR.S265806.eCollection 2020.

Hasan Tahir 1 2Arumugam Moorthy 3Antoni Chan 4

117

Depression in patients with spondyloarthritis: prevalence, incidence, risk factors, mechanisms and management

Ther Adv Musculoskelet Dis. 2020 Nov 2;12:1759720X20970028.

doi: 10.1177/1759720X20970028. eCollection 2020.

Joel T Parkinson 1Éimear M Foley 2Deepak R Jadon 3Golam M Khandaker 2

118

Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Nat Rev Rheumatol. 2021 Jun 10. doi: 10.1038/s41584-021-00625-y.Online ahead of print.

Daniele Mauro 1Ranjeny Thomas 2Giuliana Guggino 3Rik Lories 4 5Matthew A Brown 6Francesco Ciccia 7

119

Children with enthesitis-related arthritis could benefit from treatments targeted for adults with spondyloarthritis

Arthritis Care Res (Hoboken). 2020 Dec 5. doi: 10.1002/acr.24529.Online ahead of print.

Pamela F Weiss 1Robert C Fuhlbrigge 2Emily von Scheven 3Daniel J Lovell 4Robert A Colbert 5Hermine I Brunner 4PRCSG Advisory Council, the CARRA Executive Committee

120

Is Treatment in Patients With Suspected Nonradiographic Axial Spondyloarthritis Effective? Six-Month Results of a Placebo-Controlled Trial

Arthritis Rheumatol. 2021 May;73(5):806-815.doi: 10.1002/art.41607. Epub 2021 Mar 24.

Tamara Rusman 1Mignon A C van der Weijden 1Michael T Nurmohamed 2Robert B M Landewé 3Janneke J H de Winter 3Bouke J H Boden 4Pierre M Bet 1Carmella M A van der Bijl 1Conny van der Laken 1Irene E van der Horst-Bruinsma 1

121

One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis

Arthritis Care Res (Hoboken). 2020 Nov 30. doi: 10.1002/acr.24523. Online ahead of print.

Bente Glintborg 1 2Ulf Lindstrom 3Daniela Di Giuseppe 4Sella Aarrestad Provan 5Bjorn Gudbjornsson 6Merete Lund Hetland 1 2Brigitte Michelsen 7 8Johan Wallman 9Kalle Aaltonen 10Anna-Mari Hokkanen 11Dan Nordström 12Tanja Schjødt Jørgensen 13Rebekka Lund Hansen 13Arni Jon Geirsson 14Kathrine Grøn 1Niels Steen Krogh 15Johan Askling 4Lars Erik Kristensen 13Lennart Jacobsson 3DANBIO (Denmark), ARTIS/SRQ (Sweden), ICEBIO (Iceland), ROB-FIN (Finland), NOR-DMARD (Norway) registries

122

Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature

Front Med (Lausanne). 2021 Apr 26;8:661101. doi: 10.3389/fmed.2021.661101.eCollection 2021.

Per Eriksson 1Johan Mölne 2Lina Wirestam 1Christopher Sjöwall 1

123

A pilot study of a nurse-led integrated care review (the INCLUDE review) for people with inflammatory rheumatological conditions in primary care: feasibility study findings

Pilot Feasibility Stud. 2021 Jan 6;7(1):9. doi: 10.1186/s40814-020-00750-7.

Samantha L Hider 1 2Milica Bucknall 3 4Clare Jinks 3 5Kelly Cooke 6Kendra Cooke 4Erandie Ediriweera Desilva 3 7Andrew G Finney 3 8Emma L Healey 3Daniel Herron 3Annabelle R Machin 3Christian D Mallen 3 5 9Simon Wathall 3Carolyn A Chew-Graham 3 5 9

124

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

Ann Rheum Dis. 2021 Jan;80(1):71-87.doi: 10.1136/annrheumdis-2020-218398. Epub 2020 Nov 6.

Peter Nash 1Andreas Kerschbaumer 2Thomas Dörner 3Maxime Dougados 4Roy M Fleischmann 5Klaus Geissler 6Iain McInnes 7Janet E Pope 8Désirée van der Heijde 9Michaela Stoffer-Marx 10Tsutomu Takeuchi 11Michael Trauner 12Kevin L Winthrop 13Maarten de Wit 14Daniel Aletaha 2Xenofon Baraliakos 15Wolf-Henning Boehncke 16Paul Emery 17John D Isaacs 18Joel Kremer 19Eun Bong Lee 20Walter P Maksymowych 21Marieke Voshaar 14Lai-Shan Tam 22Yoshiya Tanaka 23Filip van den Bosch 24René Westhovens 25Ricardo Xavier 26Josef S Smolen 27

125

Loss and gain of bone in spondyloarthritis: what drives these opposing clinical features?

Ther Adv Musculoskelet Dis. 2020 Oct 30;12:1759720X20969260.doi: 10.1177/1759720X20969260. eCollection 2020.

Gavin Clunie 1Nicole Horwood 2

126

The societal impact of a biologic treatment of ankylosing spondylitis: a case study based on secukinumab

J Comp Eff Res. 2021 Feb;10(2):143-155. doi: 10.2217/cer-2020-0077. Epub 2020 Nov 30.

Sebastian Himmler 1Jennifer C Branner 1Dennis A Ostwald 1 2

127

Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic

J Rheumatol. 2020 Nov 15;jrheum.201017. doi: 10.3899/jrheum.201017. Online ahead of print.

Michael D George 1Shilpa Venkatachalam 1Shubhasree Banerjee 1Joshua F Baker 1Peter A Merkel 1Kelly Gavigan 1David Curtis 1Maria I Danila 1Jeffrey R Curtis 1W Benjamin Nowell 1

128

Pregnancy in axial spondyloarthropathy: A systematic review & meta-analysis

Semin Arthritis Rheum. 2020 Dec;50(6):1269-1279.doi: 10.1016/j.semarthrit.2020.08.011. Epub 2020 Aug 29.

Sinead Maguire 1Tom O'Dwyer 2David Mockler 3Finbar O'Shea 4Fiona Wilson 5

129

Comparison of Men and Women With Axial Spondyloarthritis in the US-Based Corrona Psoriatic Arthritis/Spondyloarthritis Registry

J Rheumatol. 2021 Apr 15;jrheum.201549. doi: 10.3899/jrheum.201549. Online ahead of print.

Philip J Mease 1Robert R McLean 1Blessing Dube 1Mei Liu 1Sabrina Rebello 1Meghan Glynn 1Esther Yi 1Yujin Park 1Alexis Ogdie 1

130

Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients

Rheumatol Ther. 2021 Apr 17. doi: 10.1007/s40744-021-00306-y. Online ahead of print.

James Pike 1Yan Dong 2James Piercy 1Nicola Booth 3Elizabeth Holdsworth 1Theresa Hunter 2

131

Infliximab treatment reduces depressive symptoms in patients with ankylosing spondylitis: an ancillary study to a randomized controlled trial (ASSERT)

Arthritis Res Ther. 2020 Sep 29;22(1):225. doi: 10.1186/s13075-020-02305-w.

Casper Webers 1 2Carmen Stolwijk 3Olga Schiepers 4Thea Schoonbrood 5Astrid van Tubergen 5 6Robert Landewé 7 8Désirée van der Heijde 9Annelies Boonen 5 6

132

Why Inhibition of IL-23 Lacked Efficacy in Ankylosing Spondylitis

Front Immunol. 2021 Mar 19;12:614255.doi: 10.3389/fimmu.2021.614255.eCollection 2021.

Dennis McGonagle 1 2Abdulla Watad 1 3 4Kassem Sharif 1 3 4Charlie Bridgewood 1

133

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

RMD Open. 2021 Apr;7(1):e001546. doi: 10.1136/rmdopen-2020-001546.

Marco Garrido-Cumbrera 1 2Helena Marzo-Ortega 3 4Laura Christen 5Pedro Plazuelo-Ramos 2Dale Webb 6Clare Jacklin 7Shantel Irwin 8Laurent Grange 9 10Souzi Makri 11Elsa Frazão Mateus 12Serena Mingolla 13Katy Antonopoulou 14Sergio Sanz-Gómez 1José Correa-Fernández 1Loreto Carmona 15Victoria Navarro-Compán 16

134

Gait characteristics in patients with ankylosing spondylitis: a systematic review

Clin Exp Rheumatol. Jan-Feb 2021;39(1):173-186. Epub 2020 Oct 5.

Julie Soulard 1Jacques Vaillant 2Clara-Themis Agier 2Nicolas Vuillerme 3

135

Bimekizumab, a Novel Humanized IgG1 Antibody That Neutralizes Both IL-17A and IL-17F

Front Immunol. 2020 Aug 21;11:1894. doi: 10.3389/fimmu.2020.01894. eCollection 2020.

Ralph Adams 1Asher Maroof 2Terry Baker 1Alastair D G Lawson 3Ruth Oliver 4Ross Paveley 5Steve Rapecki 1Stevan Shaw 2Pavan Vajjah 4Shauna West 5Meryn Griffiths 6

136

Drug retention, inactive disease and response rates in 1860 patients with axial spondyloarthritis initiating secukinumab treatment: routine care data from 13 registries in the EuroSpA collaboration

RMD Open. 2020 Sep;6(3):e001280. doi: 10.1136/rmdopen-2020-001280.

Brigitte Michelsen 1 2 3Ulf Lindström 4Catalin Codreanu 5Adrian Ciurea 6Jakub Zavada 7Anne Gitte Loft 8 9Manuel Pombo-Suarez 10Fatos Onen 11Tore K Kvien 3Ziga Rotar 12Maria Jose Santos # 13Florenzo Iannone # 14Anna-Mari Hokkanen 15Bjorn Gudbjornsson 16Johan Askling 17Ruxandra Ionescu 5Michael J Nissen 18Karel Pavelka 19Carlos Sanchez-Piedra 20Servet Akar 21Joseph Sexton 3Matija Tomsic 12Helena Santos 22Marco Sebastiani 23Jenny Österlund 15Arni Jon Geirsson 24Gary Macfarlane 25Irene van der Horst-Bruinsma 26Stylianos Georgiadis 27Cecilie Heegaard Brahe 27Lykke Midtbøll Ørnbjerg 27Merete Lund Hetland # 27 28Mikkel Østergaard # 27 28

137

Ankylosing spondylitis and undifferentiated spondyloarthritis: The relationship between living with these diseases and psychological well-being

Musculoskeletal Care. 2020 Sep 18. doi: 10.1002/msc.1513. Online ahead of print.

Kate Kelly 1

138

Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment

Rheumatol Ther. 2020 Dec;7(4):867-882. doi: 10.1007/s40744-020-00233-4.Epub 2020 Sep 16.

Luca Navarini 1Francesco Caso 2Luisa Costa 3Damiano Currado 4Liliana Stola 4Fabio Perrotta 5Lorenzo Delfino 6Michela Sperti 7Marco A Deriu 7Piero Ruscitti 8Viktoriya Pavlych 8Addolorata Corrado 9Giacomo Di Benedetto 10 11Marco Tasso 3Massimo Ciccozzi 12Alice Laudisio 13Claudio Lunardi 6Francesco Paolo Cantatore 9Ennio Lubrano 5Roberto Giacomelli 3 8Raffaele ScarpaAntonella Afeltra 4

139

Performance and Predictors of Minimal Disease Activity Response in Peripheral Spondyloarthritis Patients Treated With Adalimumab

Arthritis Care Res (Hoboken). 2020 Sep 16. doi: 10.1002/acr.24442. Online ahead of print.

Laura C Coates 1Sonya Abraham 2William Tillett 3Philip J Mease 4Sofia Ramiro 5Tianshuang Wu 6Xin Wang 6Aileen L Pangan 6In-Ho Song 6

140

Do All Rigid and Unbalanced Spines Present the Same Risk of Dislocation After Total Hip Arthroplasty? A Comparison Study Between Patients With Ankylosing Spondylitis and History of Spinal Fusion

J Arthroplasty. 2020 Dec;35(12):3594-3600. doi: 10.1016/j.arth.2020.06.048. Epub 2020 Jun 24.

Akhil Katakam 1Hany S Bedair 1Christopher M Melnic 1

141

Contemporary Primary Total Knee Arthroplasty is Durable in Patients Diagnosed With Ankylosing Spondylitis

J Arthroplasty. 2020 Nov;35(11):3161-3165. doi: 10.1016/j.arth.2020.06.033. Epub 2020 Jun 17.

Aaron R Owen 1James R Markos 1Tad M Mabry 1Michael J Taunton 1Daniel J Berry 1Matthew P Abdel 1

142

Autoimmune Conditions: Ankylosing Spondylitis

FP Essent. 2020 Jul;494:30-35.

Martha McGarey Metzgar 1

143

Hearing Loss in Patients With Ankylosing Spondylitis: A Systematic Review and Metaanalysis

J Rheumatol. 2021 Jan 1;48(1):40-47. doi: 10.3899/jrheum.200276. Epub 2020 May 15.

Flora Yan 1Priyanka D Reddy 2Shaun A Nguyen 2Celine Ward 3Ted A Meyer 2

144

Risks of solid cancers in elderly persons with osteoarthritis or ankylosing spondylitis

Rheumatology (Oxford). 2020 Dec 1;59(12):3817-3825.doi: 10.1093/rheumatology/keaa166.

Michael M Ward 1, Sara Alehashemi 1

145

Association of body mass index on disease activity in axial spondyloarthritis: systematic review and meta-analysis

RMD Open. 2020 May;6(1):e001225. doi: 10.1136/rmdopen-2020-001225.

Jean W Liew 1, Irvin J Huang 2, Diana N Louden 3, Namrata Singh 2, Lianne S Gensler 4

146

Back pain, ankylosing spondylitis and social media usage; a descriptive analysis of current activity

Rheumatol Int. 2020 Sep;40(9):1493-1499. doi: 10.1007/s00296-020-04600-w.Epub 2020 May 19.

Elizabeth Reilly 1 2, Raj Sengupta 3

147

Revision Total Hip Arthroplasty in Patients With Ankylosing Spondylitis: Long-Term Results

J Arthroplasty. 2020 Sep;35(9):2573-2580. doi: 10.1016/j.arth.2020.04.071. Epub 2020 Apr 27.

Brandon R Bukowski 1, Nicholas J Clark 1, Michael J Taunton 1, Brett A Freedman 1, Daniel J Berry 1, Matthew P Abdel 1

148

Low Vitamin D Levels Predict Mortality in Ankylosing Spondylitis Patients: A Nationwide Population-Based Cohort Study

Nutrients. 2020 May 13;12(5):1400. doi: 10.3390/nu12051400.

Niv Ben-Shabat 1, Abdulla Watad 1 2 3, Aviv Shabat 4, Nicola Luigi Bragazzi 5, Doron Comaneshter 6, Arnon D Cohen 6 7, Howard Amital 1 2